Literature DB >> 32955921

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?

Mathieu Blot1,2, Abderrahmane Bourredjem3, Christine Binquet2,3, Lionel Piroth1,3.   

Abstract

Entities:  

Year:  2021        PMID： 32955921     DOI： 10.1164/rccm.202007-2924LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  Eur J Clin Pharmacol       Date:  2021-02-02       Impact factor: 3.064

2.  Benefits of Using Dapsone in Patients Hospitalized with COVID-19.

Authors:  Badar A Kanwar; Asif Khattak; Jenny Balentine; Jong Hoon Lee; Richard E Kast
Journal:  Vaccines (Basel)       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.